Filter
309
Text search:
assays
Featured
Recommendations
39
New Publications
62
Language
Document type
No document type
143
Guidelines
83
Studies & Reports
39
Fact sheets
17
Manuals
12
Strategic & Response Plan
12
Situation Updates
2
Training Material
1
Countries / Regions
Western and Central Europe
14
India
11
Global
10
Tanzania
8
South Africa
8
Eastern Europe
8
Russia
6
Nigeria
5
Germany
5
Kenya
5
Latin America and the Carribbean
5
Africa
4
Liberia
3
Bangladesh
3
Sierra Leone
2
Uganda
2
Nepal
2
Syria
2
Cambodia
2
Malawi
2
Mozambique
2
Brazil
2
Ukraine
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Asia
2
Guinea
1
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Ethiopia
1
Cameroon
1
Ghana
1
Zimbabwe
1
Philippines
1
Pakistan
1
Afghanistan
1
Chad
1
Rwanda
1
Sudan
1
Argentina
1
Colombia
1
El Salvador
1
Angola
1
Lesotho
1
Sri Lanka
1
Chile
1
Yemen
1
East and Southern Africa
1
Bhutan
1
Venezuela
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
68
Clinical Guidelines
54
Pharmacy & Technologies
22
Public Health
12
Women & Child Health
6
Key Resources
6
Toolboxes
TB
67
HIV
47
COVID-19
42
NTDs
26
Rapid Response
10
AMR
10
Zika
8
Polio
6
Refugee
6
Pharmacy
6
Malaria
5
Ebola & Marburg
4
NCDs
4
Mental Health
3
Specific Hazards
3
2.0 Rapid Response
3
Conflict
2
Natural Hazards
2
Caregiver
2
Planetary Health
2
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence
...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release
...
UNAIDS/WHO 2015 | Reference
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new co
...
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir
...
Update 19 May 2016
DOI http://dx.doi.org/ 10.1055/s-0030-1256439 Online-Publikation: 10. 5. 2011 Pneumologie 2011; 65: 359–378
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera
...
Ciudad de México, México - 26 al 28 de mayo del 2014
Antimicrobials are used in veterinary medicine to treat infectious diseases in animals caused or complicated by microorganisms, mainly bacteria, or to prevent the development or spread of infection in healthy animals.
